Founded in 2000 and headquartered near Cincinnati, AtriCure develops and manufactures medical devices for treating atrial fibrillation and managing pain after surgery. Its AtriClip left atrial appendage system is the most widely sold device of its kind worldwide, while its Isolator Synergy system became the first device FDA-approved for surgical treatment of persistent Afib. With more than 1,400 employees and products sold in approximately 50 countries, AtriCure also supports clinical research and professional training around its therapies.
CE Mark Approval
registration
AtriCure Quality Policy
compliance_program